Pinealon

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed as part of the Khavinson peptide bioregulator family, designed to support brain health and cognitive function. The peptide is proposed to have specific affinity for brain tissue, potentially supporting neuronal function and protecting against age-related cognitive decline. Research suggests Pinealon may influence gene expression related to neuronal protection and neurotransmitter regulation. The Khavinson peptide approach is based on the concept of tissue-specific short peptides that may restore optimal gene expression patterns altered by aging or disease. Studies conducted primarily in Russian research institutions indicate potential benefits for memory, attention, and cognitive performance in aging subjects. Pinealon is typically administered as a nasal spray or sublingual preparation for enhanced brain delivery. While preliminary research is promising, the peptide requires larger controlled clinical trials to establish efficacy and safety. The approach represents an emerging field of peptide bioregulation in longevity and cognitive health research.

The literature is dominated by a single research group (Khavinson et al.), with limited independent replication. No large double-blind trials in major international journals were found; human efficacy for cognition or brain aging is unproven.

Synthetic tripeptide (Glu-Asp-Arg) in the Khavinson bioregulator family, typically administered intranasally or sublingually in research contexts; no well-characterized human pharmacokinetic data (half-life, dosing) were found in reliable sources.